These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 35652240)

  • 1. Clinical relevance of rheumatoid factor and anti-citrullinated peptides in fibrotic interstitial lung disease.
    Zheng B; Donohoe K; Hambly N; Johannson KA; Assayag D; Fisher JH; Manganas H; Marcoux V; Khalil N; Kolb M; Ryerson CJ;
    Respirology; 2022 Oct; 27(10):854-862. PubMed ID: 35652240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung imaging patterns in connective tissue disease-associated interstitial lung disease impact prognosis and immunosuppression response.
    Zheng B; Marinescu DC; Hague CJ; Muller NL; Murphy D; Churg A; Wright JL; Al-Arnawoot A; Bilawich AM; Bourgouin P; Cox G; Durand C; Elliot T; Ellis J; Fisher JH; Fladeland D; Grant-Orser A; Goobie GC; Guenther Z; Haider E; Hambly N; Huynh J; Johannson KA; Karjala G; Khalil N; Kolb M; Leipsic J; Lok SD; MacIsaac S; McInnis M; Manganas H; Marcoux V; Mayo J; Morisset J; Scallan C; Sedlic T; Shapera S; Sun K; Tan V; Wong AW; Ryerson CJ
    Rheumatology (Oxford); 2024 Oct; 63(10):2734-2740. PubMed ID: 38336872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.
    Tyker A; Ventura IB; Lee CT; Strykowski R; Garcia N; Guzy R; Jablonski R; Vij R; Strek ME; Chung JH; Adegunsoye A
    Sci Rep; 2021 Nov; 11(1):22821. PubMed ID: 34819525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung function trajectory in progressive fibrosing interstitial lung disease.
    Oldham JM; Lee CT; Wu Z; Bowman WS; Pugashetti JV; Dao N; Tonkin J; Seede H; Echt G; Adegunsoye A; Chua F; Maher TM; Garcia CK; Strek ME; Newton CA; Molyneaux PL
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34737223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.
    Hambly N; Farooqi MM; Dvorkin-Gheva A; Donohoe K; Garlick K; Scallan C; Chong SG; MacIsaac S; Assayag D; Johannson KA; Fell CD; Marcoux V; Manganas H; Morisset J; Comes A; Fisher JH; Shapera S; Gershon AS; To T; Wong AW; Sadatsafavi M; Wilcox PG; Halayko AJ; Khalil N; Cox G; Richeldi L; Ryerson CJ; Kolb M
    Eur Respir J; 2022 Oct; 60(4):. PubMed ID: 35273032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study.
    Chan C; Ryerson CJ; Dunne JV; Wilcox PG
    BMC Pulm Med; 2019 Oct; 19(1):192. PubMed ID: 31672127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and risk factors of interstitial pneumonia with autoimmune features.
    Vahidy S; Agyeman J; Zheng B; Donohoe K; Hambly N; Johannson KA; Assayag D; Fisher JH; Manganas H; Marcoux V; Khalil N; Kolb M; Ryerson CJ; ; Wong AW; Lok S; Morisset J; Fell CD; Shapera S; Gershon AS; Cox G; Halayko AJ; Sadatsafavi M; Wilcox PG; To T
    Respir Med; 2024 Jan; 221():107500. PubMed ID: 38142756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial Lung Disease: A Review.
    Maher TM
    JAMA; 2024 May; 331(19):1655-1665. PubMed ID: 38648021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors for progressive pulmonary fibrosis in connective tissue disease-related interstitial lung disease.
    Kim K; Lee J; Jo YS
    Ther Adv Respir Dis; 2023; 17():17534666231212301. PubMed ID: 37991015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of antifibrotic agents in the treatment of CTD-ILD and RA-ILD: A systematic review and meta-analysis.
    Yang M; Wu Y; Liu X; Zhao C; Li T; Li T; Zhang X; Jiang H; Mao B; Liu W
    Respir Med; 2023 Sep; 216():107329. PubMed ID: 37315742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of rheumatoid arthritis and connective tissue disease-related interstitial lung disease with pulmonary physiologic test, HRCT, and patient-based measures of dyspnea and functional disability.
    Topcu A; Mursaloglu HH; Yalcinkaya Y; Karakurt S; Yagiz B; Alaca Z; Demir M; Coskun BN; Dalkilic E; Inanc N
    Clin Rheumatol; 2021 Sep; 40(9):3797-3805. PubMed ID: 33811590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma LTBP2 as a potential biomarker in differential diagnosis of connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis: a pilot study.
    Zou M; Hu X; Song W; Gao H; Wu C; Zheng W; Cheng Z
    Clin Exp Med; 2023 Dec; 23(8):4809-4816. PubMed ID: 37864077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between idiopathic interstitial pneumonias (IIPs) and connective tissue disease-related interstitial lung disease (CTD-ILD): A narrative review.
    Enomoto N
    Respir Investig; 2024 May; 62(3):465-480. PubMed ID: 38564878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria.
    Bozzao F; Tomietto P; Baratella E; Kodric M; Cifaldi R; Della Porta R; Prearo I; Pirronello SMG; Confalonieri P; Ruaro B; Fischetti F; Fabris B
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109752
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
    Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study.
    Sambataro G; Libra A; Spicuzza L; Palmucci S; Conti P; Spagnolo E; Colaci M; Malatino L; Orlandi M; Sambataro D; Vancheri C
    Respiration; 2023; 102(6):405-415. PubMed ID: 37231870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of connective tissue disease-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
    Tian M; Huang W; Ren F; Luo L; Zhou J; Huang D; Tang L
    Clin Rheumatol; 2020 Feb; 39(2):575-583. PubMed ID: 31758424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease trajectories in interstitial lung diseases - data from the EXCITING-ILD registry.
    Buschulte K; Kabitz HJ; Hagmeyer L; Hammerl P; Esselmann A; Wiederhold C; Skowasch D; Stolpe C; Joest M; Veitshans S; Höffgen M; Maqhuzu P; Schwarzkopf L; Hellmann A; Pfeifer M; Behr J; Karpavicius R; Günther A; Polke M; Höger P; Somogyi V; Lederer C; Markart P; Kreuter M
    Respir Res; 2024 Mar; 25(1):113. PubMed ID: 38448953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function Trajectory.
    Matson SM; Baqir M; Moua T; Marll M; Kent J; Iannazzo NS; Boente RD; Donatelli JM; Dai J; Diaz FJ; Demoruelle MK; Hamblin MB; Mathai SK; Ryu JH; Pope K; Walker CM; Lee JS
    Chest; 2023 Apr; 163(4):861-869. PubMed ID: 36470416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.